MedPath

Assessment of a Knee Brace in Patients With Osteoarthritis

Phase 4
Conditions
Osteoarthritis
Registration Number
NCT02706106
Lead Sponsor
Irmandade da Santa Casa de Misericordia de Sao Paulo
Brief Summary

It is a controlled clinical trial randomized, double-blind evaluator. Will be considered eligible patients, individuals of both sexes, aged 40 -60, to submit at least four items of knee osteoarthrosis classification criteria, according to the American College of Rheumatology, pain above four points in the visual analogue scale (VAS), diagnosed with knee osteoarthritis and who sought physical therapy treatment.

Patients will be randomized by a number sequence generated by a computer using Microsoft Excel (Microsoft Corporation, Redmond, Washington), in opaque envelopes by researcher who will not attend the study.Patients will be divided into two groups: group with knee patellar hole or group without knee patellar hole. Shortly after the selection of the knee, the patient will have his eyes blind or cover in order to keep it '' blind '' regarding the type of knee brace that it would use.

Finally evaluator 1 will cover the knee with a black cloak, making the second evaluator ''blind '' regarding the type of knee brace that will be used.

Two investigators will carry out the data collection. The first evaluator will collect information on the clinical characteristics of patients, including evaluation form, numerical pain scale, which measures the intensity of pain, test Time Up and Go (TUG) test that measures the basic mobility of movement and test walking eight meters, whose purpose is to measure the time that the individual takes to walk a distance of eight meters.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
108
Inclusion Criteria
  • individuals of both sexes
  • aged 40 -60
  • at least four items of knee osteoarthrosis classification criteria, according to the American College of Rheumatology,
  • pain above four points in the visual analogue scale (VAS)
  • diagnosed with knee osteoarthritis
  • no physical therapy treatment prior
Exclusion Criteria
  • neurological impairment
  • partial or total knee prosthesis
  • cardio-respiratory diseases
  • pregnant women
  • individuals who failed to perform the tests proposed

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Change on pain sensationPain will be measured before and right after or maximum five minutes after wearing the brace knee

Change on pain sensation will be compared from the baseline (before wearing the brace knee) with the pain sensation right after or maximum five minutes after wearing the brace knee. This evaluation will be performed asking the patient to identify their pain sensation by the visual analogue scale (VAS).

Secondary Outcome Measures
NameTimeMethod
Change on leg functionLeg function will be measured before and right after or maximum five minutes after wearing the brace knee

Change on leg function will be measured before wearing the knee brace (baseline) and compared with right after or maximum five minutes after wearing the knee brace evaluation. Leg function will be assessed by Time Up and Go (TUG) test.

Change on agilityAgility will be measured before and right after or maximum five minutes after wearing the brace knee

Change on agility will be measured before wearing the knee brace (baseline) and compared to right after or maximum five minutes after wearing the brace knee evaluation. Agility will be assessed by 8 Meter Walk test. The time to complete this test will be recorded by the researchers and this time will be the result considered for comparison from baseline and after wearing the knee brace.

Trial Locations

Locations (1)

Irmandade da Santa Casa de Misericórdia de São Paulo

🇧🇷

São Paulo, Brazil

Irmandade da Santa Casa de Misericórdia de São Paulo
🇧🇷São Paulo, Brazil

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.